Cargando…
Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586789/ https://www.ncbi.nlm.nih.gov/pubmed/32524674 http://dx.doi.org/10.1111/tbj.13930 |
| _version_ | 1783600063029706752 |
|---|---|
| author | van Zeeland, Marianne Westhoff, Paulien Wauters, Carla Bult, Peter Werner, Annelies Laurens, Nicole Strobbe, Luc Meijer, Hanneke |
| author_facet | van Zeeland, Marianne Westhoff, Paulien Wauters, Carla Bult, Peter Werner, Annelies Laurens, Nicole Strobbe, Luc Meijer, Hanneke |
| author_sort | van Zeeland, Marianne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7586789 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75867892020-10-30 Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? van Zeeland, Marianne Westhoff, Paulien Wauters, Carla Bult, Peter Werner, Annelies Laurens, Nicole Strobbe, Luc Meijer, Hanneke Breast J Commentaries John Wiley and Sons Inc. 2020-06-10 2020-09 /pmc/articles/PMC7586789/ /pubmed/32524674 http://dx.doi.org/10.1111/tbj.13930 Text en © 2020 The Authors. The Breast Journal published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries van Zeeland, Marianne Westhoff, Paulien Wauters, Carla Bult, Peter Werner, Annelies Laurens, Nicole Strobbe, Luc Meijer, Hanneke Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title | Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title_full | Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title_fullStr | Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title_full_unstemmed | Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title_short | Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients? |
| title_sort | omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: how can we select patients? |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586789/ https://www.ncbi.nlm.nih.gov/pubmed/32524674 http://dx.doi.org/10.1111/tbj.13930 |
| work_keys_str_mv | AT vanzeelandmarianne omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT westhoffpaulien omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT wauterscarla omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT bultpeter omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT wernerannelies omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT laurensnicole omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT strobbeluc omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients AT meijerhanneke omissionofaxillarylymphnodedissectionafterneoadjuvantchemotherapyforclinicallynodepositivebreastcancerhowcanweselectpatients |